The Limitations Of Anti-Inflammatory Drugs For The Treatment Of Alzheimer's Disease [Seeking Alpha]
INmune Bio Inc. - Common stock (INMB)
Company Research
Source: Seeking Alpha
Neuroinflammation in Alzheimer's disease is primarily caused by oxidative and nitrosative stress. Inhibiting the formation of peroxynitrite, scavenging peroxynitrite, and partially reversing oxidation and nitration may stabilize early Alzheimer's disease and slow down the progression of moderate Alzheimer's disease. With anti-amyloid and anti-tau drugs not producing any breakthrough results for Alzheimer's disease, treatments that modulate inflammation appear to be positioning themselves as the next major line of attack against the disease. Several companies – some of which are listed below - are working on drugs that reduce neuroinflammation and/or increase beneficial immune responses to remove amyloid and other “cellular debris”. Leading Immune Modulating Drug Candidates for Alzheimer's Disease INmune Bio's ( INMB ) XPro1595 Coya Therapeutics' ( COYA ) COYA302 Alector's ( ALEC ) AL101 For reasons to be discussed below, it is doubtful that any of these treatments will
Show less
Read more
Impact Snapshot
Event Time:
INMB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INMB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INMB alerts
High impacting INmune Bio Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
INMB
News
- INmune Bio Inc. to Join Russell 3000® Index [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. to Join Russell 3000® IndexGlobeNewswire
- INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business UpdateGlobeNewswire
INMB
Sec Filings
- 6/26/24 - Form 4
- 6/13/24 - Form 8-K
- 6/12/24 - Form 4
- INMB's page on the SEC website